Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$81.22 USD
+0.38 (0.47%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $82.97 +1.75 (2.15%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/31/24 |
---|---|
Current Quarter | 1.10 |
EPS Last Quarter | 0.94 |
Last EPS Surprise | 9.30% |
ABR | 2.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.03 |
Next Year | 3.86 |
EPS (TTM) | 4.03 |
P/E (F1) | 20.18 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 861.68M | 868.22M | 3.53B | 3.65B |
# of Estimates | 1 | 1 | 3 | 3 |
High Estimate | 861.68M | 868.22M | 3.55B | 3.67B |
Low Estimate | 861.68M | 868.22M | 3.51B | 3.63B |
Year ago Sales | 820.20M | 832.16M | 3.37B | 3.53B |
Year over Year Growth Est. | 5.06% | 4.33% | 4.91% | 3.25% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.10 | 0.99 | 4.03 | 3.86 |
# of Estimates | 1 | 1 | 4 | 3 |
Most Recent Consensus | NA | NA | NA | 3.90 |
High Estimate | 1.10 | 0.99 | 4.26 | 4.01 |
Low Estimate | 1.10 | 0.99 | 3.86 | 3.66 |
Year ago EPS | 1.03 | 1.07 | 4.01 | 4.03 |
Year over Year Growth Est. | 6.80% | -7.48% | 0.50% | -4.18% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 2 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 1.10 | 0.99 | 4.03 | 3.86 |
7 Days Ago | 1.10 | 0.99 | 4.03 | 3.91 |
30 Days Ago | 1.10 | 0.99 | 4.03 | 3.91 |
60 Days Ago | 1.10 | 0.99 | 4.09 | 4.06 |
90 Days Ago | 1.10 | 0.99 | 4.12 | 4.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.10 | 0.99 | 4.26 | 3.78 |
Zacks Consensus Estimate | 1.10 | 0.99 | 4.03 | 3.86 |
Earnings ESP | 0.00% | 0.00% | 5.84% | -1.99% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.94 | 0.99 | 1.07 | 1.03 | NA |
Estimate | 0.86 | 0.87 | 0.88 | 0.71 | NA |
Difference | 0.08 | 0.12 | 0.19 | 0.32 | 0.18 |
Surprise | 9.30% | 13.79% | 21.59% | 45.07% | 22.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more